How many insider trades does FilingIQ track for ADTX?

FilingIQ tracks 44 Form 4 insider transactions for ADTX (Aditxt, Inc.), covering filings from Jul 24, 2020 onwards. 4 of those were filed in the last 90 days.

Are ADTX insiders net buyers or net sellers?

Across the full Form 4 history for ADTX, 25 transactions (57%) were open-market purchases and 7 (16%) were open-market sales. Compensatory awards and option exercises are filtered out of these counts.

Where does ADTX insider data come from?

Every transaction shown on this page is sourced directly from SEC EDGAR Form 4 filings. FilingIQ parses the raw XML, normalises insider identity across reporting variations, and scores each trade on its multi-factor composite model.

What sector is ADTX in?

Aditxt, Inc. (ADTX) is classified in the Healthcare sector, specifically Biotechnology, with a current market capitalisation of $471248.

ADTX insider trading

NasdaqCM Healthcare

Aditxt, Inc. — scored insider trade history from SEC Form 4 filings, parsed and contextualised by FilingIQ.

Total Form 4 trades

Last 90 days

Buys / sells

57% / 16%

Market cap

$471248

About Aditxt, Inc.

Aditxt, Inc., a commercial-stage company, discovers and develops products in the areas of immune health, precision health, population health, women's health, and neurologic health. The company develops AditxtScore that enable individuals to understand, manage, and monitor their immune profiles in order to be informed about attacks on or by their immune system; and Apoptotic DNA Immunotherapy, a nucleic acid-based technology that utilizes an approach that mimics the way the body naturally induces tolerance to its tissues. It also develops ADI-100 for skin grafting, psoriasis, type 1 diabetes, and multiple sclerosis. Aditxt, Inc. has a license agreement with Loma Linda University and Leland Stanford Junior University. The company was formerly known as ADiTx Therapeutics, Inc. and changed its name to Aditxt, Inc. in July 2021. Aditxt, Inc. was incorporated in 2017 and is headquartered in Mountain View, California.

Company website: www.aditxt.com

ADTX insider activity at a glance

FilingIQ has scored 44 insider transactions for ADTX since Jul 24, 2020. The most recent filing in our index is dated Apr 24, 2026.

Across the full history, 25 open-market purchases and 7 open-market sales were filed under transaction codes P and S respectively. Compensatory share awards (code A) and option exercises (code M) are tracked separately and not counted here.

The average FilingIQ composite score on ADTX insider trades is 58.5/100, produced by FilingIQ's multi-factor Form 4 model. Model framework documented at methodology.

View live ADTX trades on FilingIQ Raw filings on SEC EDGAR

Other Healthcare tickers with recent insider activity

UTHR 1,098

UNITED THERAPEUTICS Corp

APLS 279

Apellis Pharmaceuticals, Inc.

KMDA 218

KAMADA LTD

BMY 185

BRISTOL MYERS SQUIBB CO

ADPT 184

Adaptive Biotechnologies Corp

GH 169

Guardant Health, Inc.

ISRG 166

INTUITIVE SURGICAL INC

VTRS 165

Viatris Inc

Frequently asked

How many insider trades does FilingIQ track for ADTX?: FilingIQ tracks 44 Form 4 insider transactions for ADTX (Aditxt, Inc.), covering filings from Jul 24, 2020 onwards. 4 of those were filed in the last 90 days.
Are ADTX insiders net buyers or net sellers?: Across the full Form 4 history for ADTX, 25 transactions (57%) were open-market purchases and 7 (16%) were open-market sales. Compensatory awards and option exercises are filtered out of these counts.
Where does ADTX insider data come from?: Every transaction shown on this page is sourced directly from SEC EDGAR Form 4 filings. FilingIQ parses the raw XML, normalises insider identity across reporting variations, and scores each trade on its multi-factor composite model.
What sector is ADTX in?: Aditxt, Inc. (ADTX) is classified in the Healthcare sector, specifically Biotechnology, with a current market capitalisation of $471248.

Methodology & sources

Every ADTX insider transaction shown on FilingIQ is parsed directly from a public SEC Form 4 XML filing. Insider identity is normalised across reporting variants (CIK changes, name spellings, related-party indirect holdings). The FilingIQ composite score is documented in full on the team page and algo disclosure. Not investment advice; see disclaimer.